Report Detail
Global (United States, European Union and China) Influenza Vaccine Market Research Report 2019-2025
- RnM3712695 |
- 30 August, 2019 |
- Global |
- 128 Pages |
- QYResearch |
- Pharma & Healthcare
Influenza vaccines are vaccines that protect against infection by Influenza viruses. A new version of the vaccine is developed twice a year, as the Influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza.
The European Centre for Disease Prevention and Control also recommends yearly vaccination of high risk groups. These groups include pregnant women, the elderly, children between six months and five years of age, those with other health problems, and those who work in healthcare.
In 2019, the market size of Influenza Vaccine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Influenza Vaccine.
This report studies the global market size of Influenza Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Influenza Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
AstraZeneca
CSL
GlaxoSmithKline
Sanofi
Altimmune
BionVax
FluGen
Folia Biotech
Genentech
Green Cross
Medicago
Moderna Therapeutics
Novavax
Shijiazhuang Yiling Pharmaceutical
SK Chemicals
UNM Pharma
Vaccitec
Market Segment by Product Type
Fluzone/Vaxigrip
FluMist
Fluarix and Flulaval
Anflu
Fluvax/Afluria
Flucelvax and Fluvirin
Market Segment by Application
Adults
Pediatrics
Senior Citizens
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Influenza Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Influenza Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Influenza Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Influenza Vaccine Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Fluzone/Vaxigrip
- 1.3.3 FluMist
- 1.3.4 Fluarix and Flulaval
- 1.3.5 Anflu
- 1.3.6 Fluvax/Afluria
- 1.3.7 Flucelvax and Fluvirin
- 1.4 Market Segment by Application
- 1.4.1 Global Influenza Vaccine Market Share by Application (2019-2025)
- 1.4.2 Adults
- 1.4.3 Pediatrics
- 1.4.4 Senior Citizens
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Influenza Vaccine Market Size
- 2.1.1 Global Influenza Vaccine Revenue 2014-2025
- 2.1.2 Global Influenza Vaccine Sales 2014-2025
- 2.2 Influenza Vaccine Growth Rate by Regions
- 2.2.1 Global Influenza Vaccine Sales by Regions 2014-2019
- 2.2.2 Global Influenza Vaccine Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Influenza Vaccine Sales by Manufacturers
- 3.1.1 Influenza Vaccine Sales by Manufacturers 2014-2019
- 3.1.2 Influenza Vaccine Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Influenza Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Influenza Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Influenza Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.3 Influenza Vaccine Price by Manufacturers
- 3.4 Key Manufacturers Influenza Vaccine Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Influenza Vaccine Market
- 3.6 Key Manufacturers Influenza Vaccine Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Fluzone/Vaxigrip Sales and Revenue (2014-2019)
- 4.1.2 FluMist Sales and Revenue (2014-2019)
- 4.1.3 Fluarix and Flulaval Sales and Revenue (2014-2019)
- 4.1.4 Anflu Sales and Revenue (2014-2019)
- 4.1.5 Fluvax/Afluria Sales and Revenue (2014-2019)
- 4.1.6 Flucelvax and Fluvirin Sales and Revenue (2014-2019)
- 4.2 Global Influenza Vaccine Sales Market Share by Type
- 4.3 Global Influenza Vaccine Revenue Market Share by Type
- 4.4 Influenza Vaccine Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Influenza Vaccine Sales by Application
6 United States
- 6.1 United States Influenza Vaccine Breakdown Data by Company
- 6.2 United States Influenza Vaccine Breakdown Data by Type
- 6.3 United States Influenza Vaccine Breakdown Data by Application
7 European Union
- 7.1 European Union Influenza Vaccine Breakdown Data by Company
- 7.2 European Union Influenza Vaccine Breakdown Data by Type
- 7.3 European Union Influenza Vaccine Breakdown Data by Application
8 China
- 8.1 China Influenza Vaccine Breakdown Data by Company
- 8.2 China Influenza Vaccine Breakdown Data by Type
- 8.3 China Influenza Vaccine Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Influenza Vaccine Breakdown Data by Company
- 9.2 Rest of World Influenza Vaccine Breakdown Data by Type
- 9.3 Rest of World Influenza Vaccine Breakdown Data by Application
- 9.4 Rest of World Influenza Vaccine Breakdown Data by Countries
- 9.4.1 Rest of World Influenza Vaccine Sales by Countries
- 9.4.2 Rest of World Influenza Vaccine Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 AstraZeneca
- 10.1.1 AstraZeneca Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Influenza Vaccine
- 10.1.4 Influenza Vaccine Product Introduction
- 10.1.5 AstraZeneca Recent Development
- 10.2 CSL
- 10.2.1 CSL Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Influenza Vaccine
- 10.2.4 Influenza Vaccine Product Introduction
- 10.2.5 CSL Recent Development
- 10.3 GlaxoSmithKline
- 10.3.1 GlaxoSmithKline Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Influenza Vaccine
- 10.3.4 Influenza Vaccine Product Introduction
- 10.3.5 GlaxoSmithKline Recent Development
- 10.4 Sanofi
- 10.4.1 Sanofi Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Influenza Vaccine
- 10.4.4 Influenza Vaccine Product Introduction
- 10.4.5 Sanofi Recent Development
- 10.5 Altimmune
- 10.5.1 Altimmune Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Influenza Vaccine
- 10.5.4 Influenza Vaccine Product Introduction
- 10.5.5 Altimmune Recent Development
- 10.6 BionVax
- 10.6.1 BionVax Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Influenza Vaccine
- 10.6.4 Influenza Vaccine Product Introduction
- 10.6.5 BionVax Recent Development
- 10.7 FluGen
- 10.7.1 FluGen Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Influenza Vaccine
- 10.7.4 Influenza Vaccine Product Introduction
- 10.7.5 FluGen Recent Development
- 10.8 Folia Biotech
- 10.8.1 Folia Biotech Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Influenza Vaccine
- 10.8.4 Influenza Vaccine Product Introduction
- 10.8.5 Folia Biotech Recent Development
- 10.9 Genentech
- 10.9.1 Genentech Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Influenza Vaccine
- 10.9.4 Influenza Vaccine Product Introduction
- 10.9.5 Genentech Recent Development
- 10.10 Green Cross
- 10.10.1 Green Cross Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Influenza Vaccine
- 10.10.4 Influenza Vaccine Product Introduction
- 10.10.5 Green Cross Recent Development
- 10.11 Medicago
- 10.12 Moderna Therapeutics
- 10.13 Novavax
- 10.14 Shijiazhuang Yiling Pharmaceutical
- 10.15 SK Chemicals
- 10.16 UNM Pharma
- 10.17 Vaccitec
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Influenza Vaccine Sales Channels
- 11.2.2 Influenza Vaccine Distributors
- 11.3 Influenza Vaccine Customers
12 Market Forecast
- 12.1 Global Influenza Vaccine Sales and Revenue Forecast 2019-2025
- 12.2 Global Influenza Vaccine Sales Forecast by Type
- 12.3 Global Influenza Vaccine Sales Forecast by Application
- 12.4 Influenza Vaccine Forecast by Regions
- 12.4.1 Global Influenza Vaccine Sales Forecast by Regions 2019-2025
- 12.4.2 Global Influenza Vaccine Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Influenza Vaccine. Industry analysis & Market Report on Influenza Vaccine is a syndicated market report, published as Global (United States, European Union and China) Influenza Vaccine Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Influenza Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
